CARMAT (ALCAR.PA)
FR0010907956 - Common Stock
ALCAR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 56 industry peers in the Health Care Equipment & Supplies industry. ALCAR may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ALCAR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
ALCAR had negative earnings in the past year.
ALCAR had a negative operating cash flow in the past year.
ALCAR had negative earnings in each of the past 5 years.
In the past 5 years ALCAR always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -98.49%, ALCAR is not doing good in the industry: 96.15% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -98.49% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-84.68%
ROA(5y)-76.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ALCAR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ALCAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALCAR has more shares outstanding
The number of shares outstanding for ALCAR has been increased compared to 5 years ago.
ALCAR has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -3.87, we must say that ALCAR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALCAR (-3.87) is worse than 90.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.87 |
ROIC/WACCN/A
WACC6.35%
2.3 Liquidity
A Current Ratio of 3.48 indicates that ALCAR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.48, ALCAR belongs to the best of the industry, outperforming 82.69% of the companies in the same industry.
A Quick Ratio of 1.69 indicates that ALCAR should not have too much problems paying its short term obligations.
ALCAR has a Quick ratio of 1.69. This is in the better half of the industry: ALCAR outperforms 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.48 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
ALCAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.63%, which is quite impressive.
Looking at the last year, ALCAR shows a very strong growth in Revenue. The Revenue has grown by 517.77%.
EPS 1Y (TTM)21.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.27%
Revenue 1Y (TTM)517.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%494.03%
3.2 Future
Based on estimates for the next years, ALCAR will show a very strong growth in Earnings Per Share. The EPS will grow by 24.87% on average per year.
Based on estimates for the next years, ALCAR will show a very strong growth in Revenue. The Revenue will grow by 164.02% on average per year.
EPS Next Y38.43%
EPS Next 2Y27.81%
EPS Next 3Y20.69%
EPS Next 5Y24.87%
Revenue Next Year74.69%
Revenue Next 2Y93.14%
Revenue Next 3Y104.58%
Revenue Next 5Y164.02%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
ALCAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALCAR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ALCAR's earnings are expected to grow with 20.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.81%
EPS Next 3Y20.69%
5. Dividend
5.1 Amount
ALCAR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CARMAT
EPA:ALCAR (1/6/2025, 7:00:00 PM)
1.082
-0.04 (-3.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners1.05%
Inst Owner ChangeN/A
Ins Owners14.85%
Ins Owner ChangeN/A
Market Cap45.88M
Analysts84.62
Price Target7.72 (613.49%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-126.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-15.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-57.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 8.3 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.76
EYN/A
EPS(NY)-0.8
Fwd EYN/A
FCF(TTM)-1.26
FCFYN/A
OCF(TTM)-1.15
OCFYN/A
SpS0.13
BVpS-0.53
TBVpS-0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -98.49% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-84.68%
ROA(5y)-76.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 25.26% | ||
| Cap/Sales | 85.08% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.48 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | -3.87 |
F-Score3
WACC6.35%
ROIC/WACCN/A
Cap/Depr(3y)21.88%
Cap/Depr(5y)26.79%
Cap/Sales(3y)278.56%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.27%
EPS Next Y38.43%
EPS Next 2Y27.81%
EPS Next 3Y20.69%
EPS Next 5Y24.87%
Revenue 1Y (TTM)517.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%494.03%
Revenue Next Year74.69%
Revenue Next 2Y93.14%
Revenue Next 3Y104.58%
Revenue Next 5Y164.02%
EBIT growth 1Y1.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.11%
EBIT Next 3Y12.89%
EBIT Next 5YN/A
FCF growth 1Y15.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.73%
OCF growth 3YN/A
OCF growth 5YN/A